Founded in 2009, Checkpoint Surgical's mission is to provide surgeons with state-of-the-art neurodevices to preserve nerves and evaluate nerve and muscle excitability in surgical procedures for better patient outcomes. In 2010, Checkpoint Surgical launched the CHECKPOINT Stimulator/Locator as its flagship product in a line of proprietary neuromuscular surgical devices.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/27/12 | $1,700,000 | Series B |
NDI Healthcare Fund | undisclosed |
| 09/28/18 | $8,800,000 |
First Analysis JumpStart NEXT Fund Mutual Capital Partners  | undisclosed |
